Both in Pharmaceuticals
Filana Therapeutics vs Celularity
Over the past year FLNA returned −27.4% and CELU returned −43.1%; their daily moves had a correlation of 0.02.
FLNA −27.4% CELU −43.1%Growth of $1, one year, split-adjusted
| Metric | FLNA | CELU |
|---|---|---|
| Price | $0.5610 | $0.8025 |
| Market cap | $27.1M | $26.0M |
| Today | −9.81% | +0.30% |
| 1 month | −39.7% | −49.8% |
| 6 months | — | −18.5% |
| Year to date | — | −27.7% |
| 1 year | — | −57.5% |
| Revenue growth (YoY) | — | −5.3% |
| Gross margin | — | 56.8% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.4× |
| Net cash | $82.7M | -$37.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 223.1% |
| Short % of float | 12.2% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).